Literature DB >> 21875922

Cardiac amyloidosis: a treatable disease, often overlooked.

Rodney H Falk1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21875922     DOI： 10.1161/CIRCULATIONAHA.110.010447

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  46 in total

1.  MRI differentiation of cardiomyopathy showing left ventricular hypertrophy and heart failure: differentiation between cardiac amyloidosis, hypertrophic cardiomyopathy, and hypertensive heart disease.

Authors:  Minako Takeda; Yasuo Amano; Masaki Tachi; Hitomi Tani; Kyoichi Mizuno; Shinichiro Kumita
Journal:  Jpn J Radiol       Date:  2013-08-31       Impact factor: 2.374

2.  Light chain amyloidosis: the heart of the problem.

Authors:  Giampaolo Merlini; Giovanni Palladini
Journal:  Haematologica       Date:  2013-10       Impact factor: 9.941

3.  Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis.

Authors:  Lauren Gray Gilstrap; Emily Niehaus; Rajeev Malhotra; Van-Khue Ton; James Watts; David C Seldin; Joren C Madsen; Marc J Semigran
Journal:  J Heart Lung Transplant       Date:  2013-11-05       Impact factor: 10.247

4.  Abdominal distension and diarrhea as the main symptoms of primary amyloidosis: A case report and literature review.

Authors:  Jian Zhang; Chuxiao Shao; Jinde Zhu; Chaoyong Tu; Xinliang Lv
Journal:  Exp Ther Med       Date:  2016-02-19       Impact factor: 2.447

5.  Cardiac amyloidosis detected on tc-99m bone scan.

Authors:  Yang Lu; John V Groth; Rajyasree Emmadi
Journal:  Nucl Med Mol Imaging       Date:  2014-12-16

Review 6.  New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis.

Authors:  Stefano Perlini; Roberta Mussinelli; Francesco Salinaro
Journal:  Curr Heart Fail Rep       Date:  2016-12

7.  Imaging cardiac amyloidosis: a pilot study using ¹⁸F-florbetapir positron emission tomography.

Authors:  Sharmila Dorbala; Divya Vangala; James Semer; Christopher Strader; John R Bruyere; Marcelo F Di Carli; Stephen C Moore; Rodney H Falk
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-20       Impact factor: 9.236

8.  Nuclear imaging of cardiac amyloidosis. 'We've only just begun'.

Authors:  Pradeep Bhambhvani; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2016-09-08       Impact factor: 5.952

9.  AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin.

Authors:  Sravan C Penchala; Stephen Connelly; Yu Wang; Miki S Park; Lei Zhao; Aleksandra Baranczak; Irit Rappley; Hannes Vogel; Michaela Liedtke; Ronald M Witteles; Evan T Powers; Natàlia Reixach; William K Chan; Ian A Wilson; Jeffery W Kelly; Isabella A Graef; Mamoun M Alhamadsheh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

10.  Cardioverter-defibrillator implantation in myeloma-associated cardiac amyloidosis.

Authors:  Alfonso Campanile; Fabiola B Sozzi; Ciro Canetta; Gian Battista Danzi
Journal:  Exp Clin Cardiol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.